{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T19:19:17Z","timestamp":1788808757189,"version":"build-2803163510"},"reference-count":41,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2023-00217471"],"award-info":[{"award-number":["RS-2023-00217471"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030943","name":"Chosun University Hospital","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100030943","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.mdpi.com"],"crossmark-restriction":true},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Periprosthetic joint infection (PJI) is one of the most serious complications following total joint arthroplasty (TJA), leading to poor functional outcomes and increased healthcare burden. Intraosseous (IO) regional antibiotic prophylaxis has emerged as a promising method for infection prevention, offering potential advantages over conventional intravenous (IV) systemic administration. This study aimed to systematically evaluate the clinical evidence on the efficacy and safety of IO prophylaxis in TJA. Materials and Methods: A comprehensive literature search was conducted in PubMed, Embase, Scopus, Web of Science, and the Cochrane Library up to 23 June 2025. Eligible studies included randomized controlled trials and observational studies reporting outcomes of IO antibiotic administration in TJA. Primary endpoints were systemic and local antibiotic concentrations (bone and fat tissue), the incidence of PJI, and complication profiles. Risk of bias was assessed using the ROB-2 and ROBINS-I tools, and meta-analyses were conducted using RevMan v 7.2.0. Results: Fifteen studies (eight RCTs, one prospective study, and six retrospective studies) were included for qualitative synthesis, of which ten were included in the meta-analysis. As compared with IV, IO administration resulted in significantly higher local antibiotic concentrations in bone (MD: 15.52 \u03bcg\/g; 95% CI: 8.60\u201322.45; p &lt; 0.0001) and fat tissue (MD: 18.15 \u03bcg\/g; 95% CI: 12.86\u201323.45; p &lt; 0.0001). IO prophylaxis was associated with a significantly lower PJI rate (OR: 0.26; 95% CI: 0.12\u20130.57; p = 0.008) without a significant difference in the incidence of complications (p = 0.66). Conclusions: IO antibiotic prophylaxis is an effective and safe strategy for infection prevention in total joint arthroplasty. By achieving superior local antibiotic concentrations and reducing PJI rates without increasing complications, this approach holds promise for broader clinical application.<\/jats:p>","DOI":"10.3390\/medicina61101750","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T06:02:52Z","timestamp":1758866572000},"page":"1750","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Efficacy and Safety of Intraosseous Versus Intravenous Antibiotic in Primary and Revision Total Joint Arthroplasty: A Systematic Review and Meta-Analysis"],"prefix":"10.3390","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-6161-8291","authenticated-orcid":false,"given":"Sunwoo","family":"Lee","sequence":"first","affiliation":[{"name":"College of Medicine, Chosun University, Gwangju 61452, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyun","family":"Kang","sequence":"additional","affiliation":[{"name":"College of Medicine, Chosun University, Gwangju 61452, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8230-7017","authenticated-orcid":false,"given":"Yonggyun","family":"Moon","sequence":"additional","affiliation":[{"name":"College of Medicine, Chosun University, Gwangju 61452, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaeyoung","family":"Hong","sequence":"additional","affiliation":[{"name":"College of Medicine, Chosun University, Gwangju 61452, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5616-4854","authenticated-orcid":false,"given":"Hyoungtae","family":"Kim","sequence":"additional","affiliation":[{"name":"College of Medicine, Chosun University, Gwangju 61452, Republic of Korea"},{"name":"Department of Orthopedic Surgery, Chosun University Hospital, Gwangju 61453, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3378-5954","authenticated-orcid":false,"given":"Suenghwan","family":"Jo","sequence":"additional","affiliation":[{"name":"College of Medicine, Chosun University, Gwangju 61452, Republic of Korea"},{"name":"Department of Orthopedic Surgery, Chosun University Hospital, Gwangju 61453, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,25]]},"reference":[{"key":"ref_1","first-page":"843","article-title":"Prosthetic Joint Infection Update","volume":"32","author":"Beam","year":"2018","journal-title":"Infect. Dis. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"i5","DOI":"10.1093\/jac\/dku247","article-title":"Epidemiology and burden of prosthetic joint infections","volume":"69","author":"Lamagni","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1302\/2633-1462.63.BJO-2024-0225.R1","article-title":"The health-economic burden of hip and knee periprosthetic joint infections in Europe: A comprehensive analysis following primary arthroplasty","volume":"6","author":"Alt","year":"2025","journal-title":"Bone Jt. Open"},{"key":"ref_4","first-page":"615","article-title":"A Clinical Review of Prosthetic Joint Infections","volume":"109","author":"DeBiase","year":"2025","journal-title":"Med. Clin."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.5371\/hp.2025.37.3.197","article-title":"A Comparison of In-vitro Staphylococcus aureus Growth on Rough and Smooth Titanium Surfaces","volume":"37","author":"Liu","year":"2025","journal-title":"Hip Pelvis"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3109\/17453677708992017","article-title":"Prophylactic antibiotics against early and late deep infections after total hip replacements","volume":"48","author":"Carlson","year":"1977","journal-title":"Acta Orthop. Scand."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.arth.2010.01.105","article-title":"Antibiotic prophylaxis in primary hip and knee arthroplasty: Comparison between cefuroxime and two specific antistaphylococcal agents","volume":"25","author":"Tyllianakis","year":"2010","journal-title":"J. Arthroplast."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1093\/cid\/cis027","article-title":"Vancomycin for surgical prophylaxis?","volume":"54","author":"Crawford","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/ans.14816","article-title":"Use of regional administration of prophylactic antibiotics in total knee arthroplasty","volume":"88","author":"Symonds","year":"2018","journal-title":"ANZ J. Surg."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1016\/j.arth.2021.03.035","article-title":"Incomplete Administration of Intravenous Vancomycin Prophylaxis is Common and Associated with Increased Infectious Complications After Primary Total Hip and Knee Arthroplasty","volume":"36","author":"Feder","year":"2021","journal-title":"J. Arthroplast."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s11999-012-2469-2","article-title":"Higher Cefazolin Concentrations with Intraosseous Regional Prophylaxis in TKA","volume":"471","author":"Young","year":"2013","journal-title":"Clin. Orthop. Relat. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"102553","DOI":"10.1016\/j.jcot.2024.102553","article-title":"Intraosseous regional antibiotic prophylaxis in total joint arthroplasty (TJA): Systematic review and meta-analysis","volume":"57","author":"Viswanathan","year":"2024","journal-title":"J. Clin. Orthop. Trauma"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.1007\/s00402-024-05513-0","article-title":"Safety and effectiveness of intraosseous regional prophylactic antibiotics in total knee arthroplasty: A systematic review and meta-analysis","volume":"144","author":"Yu","year":"2024","journal-title":"Arch. Orthop. Trauma Surg."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1530\/EOR-22-0130","article-title":"Intraosseous regional prophylactic antibiotics decrease the risk of infection in total knee arthroplasty compared with intravenous antibiotics: A systematic review and meta-analysis","volume":"8","author":"Lei","year":"2023","journal-title":"EFORT Open Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.arth.2022.10.023","article-title":"Intraosseous Regional Administration of Antibiotic Prophylaxis for Total Knee Arthroplasty: A Systematic Review","volume":"38","author":"Miltenberg","year":"2023","journal-title":"J. Arthroplast."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"ref_18","unstructured":"Kim, S.Y., Park, J.E., Seo, H.J., Lee, Y.J., Jang, B.H., Son, H.J., Suh, H.S., and Shin, C.M. (2011). NECA\u2019s Guidance for Undertaking Systematic Reviews and Meta-Analyses for Intervention, National Evidence-based Healthcare Collaborating Agency."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1177\/0962280216669183","article-title":"Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range","volume":"27","author":"Luo","year":"2018","journal-title":"Stat. Methods Med. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/jrsm.1429","article-title":"Optimally estimating the sample standard deviation from the five-number summary","volume":"11","author":"Shi","year":"2020","journal-title":"Res. Synth. Methods"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1177\/09622802231172043","article-title":"Detecting the skewness of data from the five-number summary and its application in meta-analysis","volume":"32","author":"Shi","year":"2023","journal-title":"Stat. Methods Med. Res."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Wan, X., Wang, W., Liu, J., and Tong, T. (2014). Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med. Res. Methodol., 14.","DOI":"10.1186\/1471-2288-14-135"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11999-013-3038-z","article-title":"The Mark Coventry Award: Higher Tissue Concentrations of Vancomycin with Low-dose Intraosseous Regional Versus Systemic Prophylaxis in TKA: A Randomized Trial","volume":"472","author":"Young","year":"2014","journal-title":"Clin. Orthop. Relat. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/j.arth.2018.03.013","article-title":"The AAHKS Clinical Research Award: Intraosseous Regional Prophylaxis Provides Higher Tissue Concentrations in High BMI Patients in Total Knee Arthroplasty: A Randomized Trial","volume":"33","author":"Chin","year":"2018","journal-title":"J. Arthroplast."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11999.0000000000000013","article-title":"The John, N. Insall Award: Higher Tissue Concentrations of Vancomycin Achieved with Intraosseous Regional Prophylaxis in Revision TKA: A Randomized Controlled Trial","volume":"476","author":"Young","year":"2018","journal-title":"Clin. Orthop. Relat. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.arth.2022.01.057","article-title":"Higher Tissue Concentrations of Vancomycin Achieved with Low-Dose Intraosseous Injection Versus Intravenous Despite Limited Tourniquet Duration in Primary Total Knee Arthroplasty: A Randomized Trial","volume":"37","author":"Spangehl","year":"2022","journal-title":"J. Arthroplast."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.arth.2023.04.028","article-title":"Otto Aufranc Award: Intraosseous Vancomycin in Total Hip Arthroplasty\u2014Superior Tissue Concentrations and Improved Efficiency","volume":"38","author":"Harper","year":"2023","journal-title":"J. Arthroplast."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1007\/s00402-023-05108-1","article-title":"Higher cefazolin concentrations in synovial fluid with intraosseous regional prophylaxis in knee arthroplasty: A randomized controlled trial","volume":"144","author":"Zhang","year":"2024","journal-title":"Arch. Orthop. Trauma Surg."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"S224","DOI":"10.1016\/j.arth.2024.02.083","article-title":"Intraosseous Versus Intravenous Vancomycin in Tourniquetless Primary Total Knee Arthroplasty: A Randomized Trial","volume":"39","author":"Wininger","year":"2024","journal-title":"J. Arthroplast."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.artd.2020.02.001","article-title":"Clinical outcome evaluation of intraosseous vancomycin in total knee arthroplasty","volume":"6","author":"Harper","year":"2020","journal-title":"Arthroplast. Today"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1097\/CORR.0000000000001919","article-title":"Intraosseous Regional Prophylactic Antibiotics Decrease the Risk of Prosthetic Joint Infection in Primary TKA: A Multicenter Study","volume":"479","author":"Parkinson","year":"2021","journal-title":"Clin. Orthop. Relat. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.arth.2020.12.034","article-title":"Intraosseous Regional Administration of Vancomycin in Primary Total Knee Arthroplasty Does Not Increase the Risk of Vancomycin-Associated Complications","volume":"36","author":"Klasan","year":"2021","journal-title":"J. Arthroplast."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1302\/0301-620X.103B6.BJJ-2020-2401.R1","article-title":"2021 Chitranjan, S. Ranawat Award: Intraosseous vancomycin reduces periprosthetic joint infection in primary total knee arthroplasty at 90-day follow-up","volume":"103-B","author":"Park","year":"2021","journal-title":"Bone Jt. J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.arth.2025.04.060","article-title":"The AAHKS Best Podium Presentation Research Award: Intraosseous Vancomycin Reduces the Rate of Periprosthetic Joint Infection Following Aseptic Revision Total Knee Arthroplasty","volume":"40","author":"McNamara","year":"2025","journal-title":"J. Arthroplast."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"S281","DOI":"10.1016\/j.arth.2023.01.043","article-title":"Intraosseous Vancomycin May Not Be Helpful in Aseptic Revision Knee Arthroplasty: A Single-Surgeon Consecutive Case Series","volume":"38","author":"Lachiewicz","year":"2023","journal-title":"J. Arthroplast."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"S305","DOI":"10.1016\/j.arth.2024.05.030","article-title":"Low Risk of Periprosthetic Joint Infection After Aseptic Revision Total Knee Arthroplasty with Intraosseous Vancomycin","volume":"39","author":"Christopher","year":"2024","journal-title":"J. Arthroplast."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0140-6736(81)92678-7","article-title":"Prophylactic cefazolin versus placebo in total hip replacement. Report of a multicentre double-blind randomised trial","volume":"317","author":"Hill","year":"1981","journal-title":"Lancet"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S0140-6736(87)91635-7","article-title":"Long-term results of prophylactic cefazolin versus placebo in total hip replacement","volume":"329","author":"Doyon","year":"1987","journal-title":"Lancet"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00264-009-0797-y","article-title":"The microbiology of the infected knee arthroplasty","volume":"34","author":"Nickinson","year":"2010","journal-title":"Int. Orthop."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5435\/00124635-200503000-00001","article-title":"Vancomycin","volume":"13","author":"McNamara","year":"2005","journal-title":"J. Am. Acad. Orthop. Surg."},{"key":"ref_41","first-page":"111","article-title":"The standard one gram dose of vancomycin is not adequate prophylaxis for MRSA","volume":"34","author":"Catanzano","year":"2014","journal-title":"Iowa Orthop. J."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/10\/1750\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T04:30:03Z","timestamp":1758947403000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/10\/1750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,25]]},"references-count":41,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["medicina61101750"],"URL":"https:\/\/doi.org\/10.3390\/medicina61101750","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,25]]}}}